Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
International Journal of Dermatology
|
July 13, 2010
Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies
Richard G Langley, Kim Papp, Robert Bissonnette, et al.
Body Image
|
December 20, 2007
Assessing body image in patients with systemic sclerosis (scleroderma): validation of the adapted Satisfaction with Appearance Scale
Leslie J Heinberg, Ian Kudel, Barbara White, et al.
Chest
|
December 11, 2003
Age and risk of pulmonary arterial hypertension in scleroderma
Lionel Schachna, Fredrick M Wigley, Betty Chang, et al.
Current Medical Research and Opinion
|
December 1, 2012
The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology
Violaine Planté-Bordeneuve, Ole B Suhr, Mathew S Maurer, et al.
American Journal of Respiratory Cell and Molecular Biology
|
April 24, 2002
Gene expression in bronchoalveolar lavage cells from scleroderma patients
Irina G Luzina, Sergei P Atamas, Robert Wise, et al.
Journal of the American Academy of Dermatology
|
February 18, 2010
A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis
Robert Bissonnette, Kim Papp, Catherine Maari, et al.
Springerplus
|
April 6, 2016
Isolated radial scar diagnosis by core-needle biopsy: Is surgical excision necessary?
Elizabeth Min Hui Kim, Andrea Hankins, Jamie Cassity, et al.
Arthritis and Rheumatism
|
August 9, 2003
Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients
Irina G Luzina, Sergei P Atamas, Robert Wise, et al.
Archives of Dermatological Research
|
May 28, 2009
Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab
Robert Bissonnette, Richard G Langley, Kim Papp, et al.
Inflammation
|
March 11, 2022
Lenabasum Reduces Porphyromonas gingivalis-Driven Inflammation
Fareeha Batool, Pierre-Yves Gegout, Céline Stutz, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
International Journal of Dermatology
|
July 13, 2010
Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies
Richard G Langley, Kim Papp, Robert Bissonnette, et al.
Body Image
|
December 20, 2007
Assessing body image in patients with systemic sclerosis (scleroderma): validation of the adapted Satisfaction with Appearance Scale
Leslie J Heinberg, Ian Kudel, Barbara White, et al.
Chest
|
December 11, 2003
Age and risk of pulmonary arterial hypertension in scleroderma
Lionel Schachna, Fredrick M Wigley, Betty Chang, et al.
Current Medical Research and Opinion
|
December 1, 2012
The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology
Violaine Planté-Bordeneuve, Ole B Suhr, Mathew S Maurer, et al.
American Journal of Respiratory Cell and Molecular Biology
|
April 24, 2002
Gene expression in bronchoalveolar lavage cells from scleroderma patients
Irina G Luzina, Sergei P Atamas, Robert Wise, et al.
Journal of the American Academy of Dermatology
|
February 18, 2010
A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis
Robert Bissonnette, Kim Papp, Catherine Maari, et al.
Springerplus
|
April 6, 2016
Isolated radial scar diagnosis by core-needle biopsy: Is surgical excision necessary?
Elizabeth Min Hui Kim, Andrea Hankins, Jamie Cassity, et al.
Arthritis and Rheumatism
|
August 9, 2003
Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients
Irina G Luzina, Sergei P Atamas, Robert Wise, et al.
Archives of Dermatological Research
|
May 28, 2009
Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab
Robert Bissonnette, Richard G Langley, Kim Papp, et al.
Inflammation
|
March 11, 2022
Lenabasum Reduces Porphyromonas gingivalis-Driven Inflammation
Fareeha Batool, Pierre-Yves Gegout, Céline Stutz, et al.
Page
of 8